밤껍질 추출물을 포함하는 화장료 조성물
    36.
    发明公开
    밤껍질 추출물을 포함하는 화장료 조성물 有权
    化妆品组合包括CHESTNUT壳提取物

    公开(公告)号:KR1020120027436A

    公开(公告)日:2012-03-21

    申请号:KR1020117031696

    申请日:2010-06-18

    CPC classification number: A61Q19/005 A61K8/97 A61K36/49

    Abstract: PURPOSE: A cosmetic composition containing nutshell extract is provided to suppress proteinase-activated receptor-2(PAR-2) and to relieve itching. CONSTITUTION: A cosmetic composition for relieving or suppressing itching contains nutshell extract as an active ingredient. The composition prevents or relieves itching caused by inflammatory dermatitis, atopic dermatitis, miliaria, frostbite, contact dermatitis, seborrheic dermatitis, or pruritus. A cosmetic composition improving skin barrier function contains the nutshell extract as an active ingredient. The extract is prepared using water, low alcohol of C1-4, 1,3-butylene glycol, or mixture thereof.

    Abstract translation: 目的:提供含有坚果壳提取物的化妆品组合物,以抑制蛋白酶激活的受体-2(PAR-2)并缓解瘙痒。 构成:用于缓解或抑制瘙痒的化妆品组合物含有坚果壳提取物作为活性成分。 该组合物预防或缓解由炎症性皮炎,特应性皮炎,睫毛膏,冻伤,接触性皮炎,脂溢性皮炎或瘙痒引起的瘙痒。 改善皮肤屏障功能的化妆品组合物含有坚果壳提取物作为活性成分。 提取物是使用C 1-4,1,3-丁二醇或其混合物的水,低级醇制备的。

    신규한 자외선 흡수제용 퀴녹살린계 화합물
    37.
    发明公开
    신규한 자외선 흡수제용 퀴녹살린계 화합물 有权
    一种用于超紫外线吸收剂的新型喹啉化合物

    公开(公告)号:KR1020120025903A

    公开(公告)日:2012-03-16

    申请号:KR1020100088083

    申请日:2010-09-08

    CPC classification number: C07D241/44 A61K9/0056 A61K47/06 A61L31/16

    Abstract: PURPOSE: A novel quinoxaline compound, isomer thereof, precursor drug thereof, or pharmaceutically acceptable salt thereof is provided to absorb UVA and UVB. CONSTITUTION: A quinoxaline compound is denoted by chemical formula 1. An UV absorber or pharmaceutical or cosmetic composition for antiaging contains the quinoxaline compound, isomer thereof, precursor drug thereof, or pharmaceutically acceptable salt, hydrate, or solvate thereof as an active ingredient.

    Abstract translation: 目的:提供一种新的喹喔啉化合物,其异构体,其前体药物或其药学上可接受的盐以吸收UVA和UVB。 构成:喹喔啉化合物由化学式1表示。用于抗衰老的紫外线吸收剂或药物或化妆品组合物含有喹喔啉化合物,其异构体,其前体药物或其药学上可接受的盐,水合物或溶剂化物作为活性成分。

    콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물
    38.
    发明公开
    콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물 审中-实审
    包含用于改善血液循环和血管健康的豆提取物的组合物

    公开(公告)号:KR1020100127728A

    公开(公告)日:2010-12-06

    申请号:KR1020100049181

    申请日:2010-05-26

    Abstract: PURPOSE: A composition containing soybean extract isolated with low alcohol is provided to improve blood circulation and to treat obesity, diabetes, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains soybean extract isolating with 1-7% of C1-5 alcohol or fraction. The C1-5 alcohol is methanol, ethanol, isopropylalcohol, n-propylalcohol, n-butanol or isobutanol. The soybean extract or fraction contains adenosine. The fraction is an ethylacetate or butanol fraction. The composition suppresses thrombosis or cholesterol generation.

    Abstract translation: 目的:提供含有用低分子量分离的大豆提取物的组合物,以改善血液循环和治疗肥胖症,糖尿病和高脂血症。 构成:用于改善血液循环的组合物含有用1-7%的C1-5醇或级分分离的大豆提取物。 C 1-5醇是甲醇,乙醇,异丙醇,正丙醇,正丁醇或异丁醇。 大豆提取物或级分含有腺苷。 馏分是乙酸乙酯或丁醇馏分。 该组合物抑制血栓形成或胆固醇的产生。

    아세틸-조효소 A 카복실라제 저해활성을 갖는트리아졸로피리다진 유도체
    39.
    发明公开
    아세틸-조효소 A 카복실라제 저해활성을 갖는트리아졸로피리다진 유도체 无效
    具有乙酰辅酶A羧酸酶的抑制活性的三唑吡啶衍生物

    公开(公告)号:KR1020080052024A

    公开(公告)日:2008-06-11

    申请号:KR1020060123982

    申请日:2006-12-07

    CPC classification number: C07D487/04

    Abstract: Triazolopyridazine derivatives are provided to inhibit acetyl-CoA carboxylase 2(ACC2), so that the compounds are useful for prevention and treatment of obesity, diabetes, hyperlipidemia and metabolic syndrome-related disease. Triazolopyridazine derivatives represented by the formula(1) have inhibitory effects on acetyl-CoA carboxylase 2, wherein X is hydrogen, pyridyl, thiophenyl, furanyl or phenyl optionally substituted by C1-5 alkyl, C1-5 alkoxy, hydroxy or halogen; Y is pyridine, thiophene or NHR2; Z is O, S, NH, methylene, ethylene or -CH(CH3)-; R1 is methyl, hydroxy or hydroxy methyl; R2 is hydrogen, C1-7 alkyl, C3-8 cycloalkyl optionally substituted by hydroxy or C1-7 alkyl, or phenyl optionally substituted by C1-5 alkyl; R3 is hydrogen, hydroxy, C1-5 alkyl, C1-5 alkoxy or halogen; R4 is hydrogen, hydroxy, C1-5 alkyl, C1-5 alkoxy, trifluoromethyl, C1-5 alkoxycarbonyl or halogen; and W is bond, C1-2 alkylene, alkenylene or alkynylene.

    Abstract translation: 提供三唑并哒嗪衍生物以抑制乙酰辅酶A羧化酶2(ACC2),使得该化合物可用于预防和治疗肥胖症,糖尿病,高脂血症和代谢综合征相关疾病。 由式(1)表示的三唑并哒嗪衍生物对乙酰辅酶A羧化酶2具有抑制作用,其中X为氢,吡啶基,噻吩基,呋喃基或任选被C 1-5烷氧基,羟基或卤素取代的苯基; Y为吡啶,噻吩或NHR2; Z是O,S,NH,亚甲基,亚乙基或-CH(CH 3) - ; R1是甲基,羟基或羟基甲基; R 2为氢,C 1-7烷基,任选被羟基或C 1-7烷基取代的C 3-8环烷基,或任选被C 1-5烷基取代的苯基; R3是氢,羟基,C1-5烷基,C1-5烷氧基或卤素; R4是氢,羟基,C1-5烷基,C1-5烷氧基,三氟甲基,C1-5烷氧基羰基或卤素; W是键,C1-2亚烷基,亚烯基或亚炔基。

    유사 세라마이드 화합물 및 그 제조방법
    40.
    发明公开
    유사 세라마이드 화합물 및 그 제조방법 审中-实审
    假神经酰胺化合物及其制备方法

    公开(公告)号:KR1020170076561A

    公开(公告)日:2017-07-04

    申请号:KR1020160169877

    申请日:2016-12-13

    Abstract: 본발명은유사세라마이드화합물및 그제조방법에관한것이다. 본발명의유사세라마이드화합물은항산화효과를제공할수 있으며, 기존천연세라마이드및 유사세라마이드화합물에비하여높은용해도등 개선된물성을나타내어제형내 다량으로포함될수 있다. 따라서, 상기유사세라마이드화합물은화장품, 의약제재, 외용제, 식품분야등 다양하게적용될수 있다.

    Abstract translation: 本发明涉及假神经酰胺化合物及其制备方法。 本发明的化合物Pseudoceramide并能提供抗氧化作用,并且表现出高的溶解度,例如改善的物理性质被包括在大量的制剂相比于常规的天然神经酰胺和pseudoceramide化合物。 因此,拟神经酰胺化合物可以应用于各种领域,如化妆品,药​​物,外用制剂和食品。

Patent Agency Ranking